Elicio Therapeutics, Inc. (ELTX)
(Delayed Data from NSDQ)
$4.85 USD
-0.05 (-1.02%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $4.78 -0.07 (-1.44%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -0.96 |
EPS Last Quarter | -1.15 |
Last EPS Surprise | -5.50% |
ABR | 2.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.68 |
Next Year | -3.07 |
EPS (TTM) | -8.80 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | 2.30M | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.96 | -0.80 | -3.68 | -3.07 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.88 | -0.79 | -3.57 | -2.78 |
High Estimate | -0.88 | -0.79 | -3.57 | -2.78 |
Low Estimate | -1.04 | -0.80 | -3.78 | -3.35 |
Year ago EPS | -2.61 | -1.27 | -6.96 | -3.68 |
Year over Year Growth Est. | 63.22% | 37.01% | 47.13% | 16.58% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.96 | -0.80 | -3.68 | -3.07 |
7 Days Ago | -0.96 | -0.80 | -3.68 | -3.07 |
30 Days Ago | -0.96 | -0.80 | -3.68 | -3.07 |
60 Days Ago | -0.96 | -0.80 | -3.68 | -3.07 |
90 Days Ago | -1.04 | -0.84 | -3.78 | -4.19 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.96 | -0.80 | -3.68 | -3.07 |
Zacks Consensus Estimate | -0.96 | -0.80 | -3.68 | -3.07 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.15 | -3.77 | -1.27 | -2.61 | NA |
Estimate | -1.09 | -0.79 | -0.80 | NA | NA |
Difference | -0.06 | -2.98 | -0.47 | NA | -1.17 |
Surprise | -5.50% | -377.22% | -58.75% | NA | -147.16% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more